Indeed, we confirmed that Onc-p53 NSCLC cells also exhibit significantly higher levels of proteasome activity requiring the ongoing expression of Onc-p53 and that PIs exhibit preferential cytotoxicity in Onc-p53 versus WT or cells lacking p53 in vitro and in vivo. This evidence concerns the gene TP53 and non-small cell lung carcinoma.